3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Carcinoma, Non-Small-Cell Lung
5
Squamous Cell Carcinoma of Head and Neck
4
Nasopharyngeal Carcinoma
3
Melanoma
3
Esophageal Neoplasms
2
Colonic Neoplasms
2
Carcinoma, Hepatocellular
2
Vascular Complications
1
Stomach Neoplasms
1
Spinocerebellar Degenerations
1
Solid Tumor
1
Recurrence
1
Rectal Neoplasms
1
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
1
Pathologic Complete Response
1
Oropharyngeal Neoplasms
1
Oligoprogressive
1
Neoplasms
1
Neoplasm Metastasis
1
NSCLC
1
Mouth Neoplasms
1
Meningeal Carcinomatosis
1
Lymphoma, Non-Hodgkin
1
Lung Neoplasms
1
Locally Advanced Rectal Cancer
1
Immune-Related Adverse Events
1
Glioma
1
Esophageal Squamous Cell Carcinoma
1
Diffuse Intrinsic Pontine Glioma
1
Colorectal Cancer Metastatic
1
Interventions
fludarabine
26
Azacitidine
24
venetoclax
23
Cyclophosphamide
21
Specimen Handling
19
fludarabine phosphate
17
Busulfan
15
Biopsy
15
Whole-Body Irradiation
14
Mycophenolic Acid
14
Melphalan
14
Tacrolimus
13
Cytarabine
13
Granulocyte Colony-Stimulating Factor
11
Decitabine
10
decitabine and cedazuridine drug combination
9
Stem Cell Transplantation
9
Sirolimus
9
Injections
9
Cyclosporine
9
Peripheral Blood Stem Cell Transplantation
8
Filgrastim
8
Thiotepa
7
ruxolitinib
5
X-Rays
5
Idarubicin
5
Methotrexate
4
Magnetic Resonance Spectroscopy
4
Cyclosporins
4
Cladribine
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Myelodysplastic Syndromes
×
Immune Checkpoint Inhibitors
×
90 days
×
Clear all
No trials found.